CLR translocation to the plasma membrane was observed in both tumor models following ECT, regardless of the specific chemotherapeutic drug employed (Figures 4A, B, Supplementary Figures S4C, D, S5C, D, S6). The gene discussed is DCLK3; the disease is neoplasm.